 Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abbott Labs (ABT – Research Report) and Phibro Animal Health (PAHC – Research Report). Abbott Labs (ABT)  The company’s shares closed last Wednesday at $110.20. According to TipRanks.com, Miksic is a 5-star analyst with an average return of 10.8% and a 65.5% success rate. Miksic covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Cardiovascular Systems, and Baxter International. Abbott Labs has an analyst consensus of Moderate Buy, with a price target consensus of $123.82, implying an 11.1% upside from current levels. In a report issued on January 25, BTIG also maintained a Buy rating on the stock with a $125.00 price target.
		  See the top stocks recommended by analysts >> Phibro Animal Health (PAHC)  The company’s shares closed last Wednesday at $15.90. According to TipRanks.com, Prasad is a 3-star analyst with an average return of 2.1% and a 44.2% success rate. Prasad covers the Healthcare sector, focusing on stocks such as Revance Therapeutics, Jazz Pharmaceuticals, and Idexx Laboratories. Phibro Animal Health has an analyst consensus of Hold, with a price target consensus of $18.33.
		  TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.  Read More on ABT:   Indices Commodities Currencies Stocks